Merck’s First COVID-19 Vaccine Candidate to Enter Phase 1 Clinical Trial in Q3
Merck (Kenilworth, NJ, USA) has announced that it is accelerating its COVID-19 vaccine development efforts and plans to begin clinical studies of its first vaccine candidate in the third quarter of this year. More...03 Aug 2020
Researchers Develop Cheaper, Rapid, and Accurate Pooling Strategy for RT-PCR-Based Detection of SARS-CoV-2
A team of researchers have developed a cheaper, rapid, and accurate pooling strategy for the RT-PCR-based detection of SARS-CoV-2 in clinical samples that could have a significant impact on large-scale population screening in the wake of the current COVID-19 pandemic. More...03 Aug 2020
Diazyme Partners with Maccura Biotechnology to Launch FDA EUA Approved SARS-CoV-2 RT-PCR Diagnostics Test
Diazyme Laboratories, Inc. (Poway, CA, USA) has entered into a partnership with Maccura Biotechnology (Sichuan, China) for the launch of a FDA EUA approved SARS-COV-2 RT-PCR diagnostics test. More...03 Aug 2020
Discovery of Endogenous Protein That Prevents Coronavirus from Fusing with Host Cells Could Help Stop COVID-19
An international team of researchers has demonstrated that a protein produced by the human immune system can strongly inhibit coronaviruses, including SARS-CoV-2, thus raising hopes of new therapeutic approaches for the treatment of COVID-19. More...03 Aug 2020
GSK and Sanofi Collaborate with US Government for Development of COVID-19 Recombinant Protein-Based Vaccine
GlaxoSmithKline plc (London, UK) and Sanofi S.A. (Paris, France) will collaborate with the US government to accelerate the development and manufacturing of a COVID-19 recombinant protein-based vaccine. More...03 Aug 2020
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Electric Cast Saw
CC4 System
New
Fetal and Maternal Monitor
F9 Series
In Other News
Coronavirus Causes Depletion of Key Immune Cells, Find Recent Studies
US COVID-19 Testing Supply Data Reveal One Million Tests Being Shipped Per Day
Seegene Allplex 2019-nCoV Assay (SARS-CoV-2) Granted Expanded FDA Emergency Use Authorization
INOVIO's COVID-19 DNA Vaccine Becomes Only Vaccine to Demonstrate Long-Term Protection in Monkeys 13 Weeks from Vaccination
World’s First COVID-19 Vaccine to Be Launched by Russia on August 10-12
Johnson & Johnson COVID-19 Vaccine Candidate Demonstrates Robust Protection in Pre-Clinical Studies
GSK and Sanofi to Supply UK with 60 Million Doses of Recombinant Protein-Based COVID-19 Vaccine
Sorrento Therapeutics to Market Columbia University’s Rapid On-Site Detection Test for SARS-CoV-2 Virus in Saliva
AACC Survey Finds Nearly Half of All US Labs Still Do Not Have Supplies for Running COVID-19 Tests
Roche’s Actemra Fails to Meet Primary and Secondary Endpoints in Phase 3 COVID-19 Associated Pneumonia Study
Study Offers New Evidence of Neuro-Axonal Damage in Mild-to-Moderate Cases of SARS-CoV-2
Truvian Sciences’ Easy Check COVID-19 IgM/IgG Test Receives FDA Emergency Use Authorization
Ultrasensitive Droplet Biosensing Method Dramatically Shortens Identification Time for COVID-19
Moderna’s COVID-19 Vaccine Successfully Generates Robust Immune Response and Protection Against SARS-CoV-2 in Monkeys
Heat Stable Subunit COVID-19 Vaccine Candidate Generates Rapid Immune Responses in Pre-Clinical Studies
Discovery of Precise T Cell Targets in COVID-19 Convalescent Patients to Help Develop Vaccines and Diagnostics
Pfizer and BioNTech Begin Global Phase 2/3 Study of Lead mRNA Vaccine Candidate Against COVID-19
Heart Abnormalities Found in Recovered Patients Suggest COVID-19 Significantly Impacts Cardiovascular System
New Reusable, Silicone Rubber Face Mask Stops Coronavirus Particles as Effectively as N95 Masks
Unique Genomic Basis of Superpowered Immune Systems of Bats Could Hold Key to Beating COVID-19 Pandemic
Understanding How Coronavirus Disguises Itself to Hide Inside Host Cells and Replicate May Help Develop COVID-19 Treatment
Pre-Existing COVID-19 / SARS-CoV-2 Immunity Found in Uninfected Individuals
Genetic Mutation Found to Cause Severe COVID-19 Symptoms in Individuals
